Delivery Order SPE2DB22D3501-SPE2DB24FUZ97
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $3,171.60 contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product, to be completed by February 26, 2024. Amerisourcebergen Drug Corp has received numerous prior federal contract awards from DLA Troop Support Medical to provide...
- This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,943.70 firm fixed-price contract is for the delivery of 250 mcg/0.5 ml syringes of the medication Ovidrel, with a completion date of May 20, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,731.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes, with a contract ceiling value of $3,323.09. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, under a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Ovidrel 250 mcg/0.5 mL syringes, with a ceiling value of $4,201.80. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, awarded on August 11, 2025. This award carries no set-aside designation and represents a competitively awarded transaction. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 8, 2025, for Ovidrel 250 mcg/0.5 ml syringes. The contract is valued at $2,189.70 and carries a firm fixed price structure with an ultimate completion date of August 11, 2025. This delivery order represents a non-set-aside award issued under competitive procedures, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a $3,671.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Ovidrel 250 micrograms per 0.5 milliliters in 0.5-milliliter syringes. This is a non-set-aside competitive award with an ultimate completion date of January 30, 2026. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed price delivery order valued at $14,966.07 with a completion date of January 26, 2024. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
- This federal contract award to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $3,372.72 and has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corporation, as the prime contractor, will provide a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,035,762.94 firm-fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has a period of performance through December 20, 2024. Amerisourcebergen holds a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUZ97Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides the Defense Logistics Agency (DLA) Troop Support Medical with pharmaceutical products and medical supplies, primarily in the form of firm fixed price delivery orders. The award, valued at up to $3,964.50, is for the procurement of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical. The contract has an ultimate completion date of March 22, 2024 and was awarded on March 21, 2024. No set-aside designation was used for this award. In addition to this delivery order, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver a comprehensive range of pharmaceuticals and medical materials to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 3/21/24 |